Camille Martin

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Positive Breast Cancer

Transcription Factor

Top Venues

Bioconjugate chemistry

University of Tours (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Tours Oct 01 2014 - Dec 01 2017

France

PHD

Publications

Ludovic Juen, Christine B Baltus, Camille Gély, Thibault Kervarrec, Ofelia Feuillâtre, Audrey Desgranges, Marie-Claude Viaud-Massuard, Camille Martin
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer. Bioconjugate chemistry 33 (2) (2022)
Ludovic Juen, Christine B Baltus, Camille Gély, Ofelia Feuillâtre, Audrey Desgranges, Marie-Claude Viaud-Massuard, Camille Martin
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model. Bioconjugate chemistry 32 (3) (2021)
Nicolas Aubrey, Emilie Allard-Vannier, Camille Martin, Francesca Bryden, Stéphanie Letast, Cyril Colas, Zineb Lakhrif, Nils Collinet, Isabelle Dimier-Poisson, Igor Chourpa, Marie-Claude Viaud-Massuard, Nicolas Joubert
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro. Bioconjugate chemistry 29 (11) (2018)